These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22076593)

  • 21. Applied biotransformations in green solvents.
    Hernáiz MJ; Alcántara AR; García JI; Sinisterra JV
    Chemistry; 2010 Aug; 16(31):9422-37. PubMed ID: 20669193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of solvent selection at exploratory and production stages in the pharmaceutical industry.
    Nicponski DR; Ramachandran PV
    Future Med Chem; 2011 Sep; 3(12):1469-73. PubMed ID: 21882940
    [No Abstract]   [Full Text] [Related]  

  • 23. Continuous processes for the production of pharmaceutical intermediates and active pharmaceutical ingredients.
    LaPorte TL; Wang C
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):738-45. PubMed ID: 17987525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Green chemistry and the evolution of flow analysis. A review.
    Melchert WR; Reis BF; Rocha FR
    Anal Chim Acta; 2012 Feb; 714():8-19. PubMed ID: 22244133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current green capillary electrophoresis and liquid chromatography methods for analysis of pharmaceutical and biomedical samples (2019-2023) - A review.
    Jankech T; Gerhardtova I; Stefanik O; Chalova P; Jampilek J; Majerova P; Kovac A; Piestansky J
    Anal Chim Acta; 2024 Sep; 1323():342889. PubMed ID: 39182966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biocatalysis for pharmaceutical intermediates: the future is now.
    Pollard DJ; Woodley JM
    Trends Biotechnol; 2007 Feb; 25(2):66-73. PubMed ID: 17184862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guidance on the establishment of acceptable daily exposure limits (ADE) to support Risk-Based Manufacture of Pharmaceutical Products.
    Sargent EV; Faria E; Pfister T; Sussman RG
    Regul Toxicol Pharmacol; 2013 Mar; 65(2):242-50. PubMed ID: 23291300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New opportunities for biocatalysis: making pharmaceutical processes greener.
    Woodley JM
    Trends Biotechnol; 2008 Jun; 26(6):321-7. PubMed ID: 18436317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-selection and assessment of green organic solvents by clustering chemometric tools.
    Tobiszewski M; Nedyalkova M; Madurga S; Pena-Pereira F; Namieśnik J; Simeonov V
    Ecotoxicol Environ Saf; 2018 Jan; 147():292-298. PubMed ID: 28850812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Green analytical chemistry metrics: A review.
    Sajid M; Płotka-Wasylka J
    Talanta; 2022 Feb; 238(Pt 2):123046. PubMed ID: 34801903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel solvents for sustainable production of specialty chemicals.
    Fadhel AZ; Pollet P; Liotta CL; Eckert CA
    Annu Rev Chem Biomol Eng; 2011; 2():189-210. PubMed ID: 22432616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Will 'green' aspects of dried blood spot sampling accelerate its implementation and acceptance in the pharmaceutical industry?
    Li F; Ploch S
    Bioanalysis; 2012 Jun; 4(11):1259-61. PubMed ID: 22720640
    [No Abstract]   [Full Text] [Related]  

  • 33. Biocatalysis in development of green pharmaceutical processes.
    Tao J; Xu JH
    Curr Opin Chem Biol; 2009 Feb; 13(1):43-50. PubMed ID: 19264533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustainability metrics: life cycle assessment and green design in polymers.
    Tabone MD; Cregg JJ; Beckman EJ; Landis AE
    Environ Sci Technol; 2010 Nov; 44(21):8264-9. PubMed ID: 20866068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Special Issue: "Organic Reactions in Green Solvents".
    Sperry J; García-Álvarez J
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27854295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New insights into liquid chromatography for more eco-friendly analysis of pharmaceuticals.
    Shaaban H
    Anal Bioanal Chem; 2016 Oct; 408(25):6929-44. PubMed ID: 27349918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expectation-Maximization Model for Substitution of Missing Values Characterizing Greenness of Organic Solvents.
    Łuczyńska G; Pena-Pereira F; Tobiszewski M; Namieśnik J
    Molecules; 2018 May; 23(6):. PubMed ID: 29843437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of Green Synthetic Chemistry from a Pharmaceutical Perspective.
    Ahsan H; Islam SU; Ahmed MB; Lee YS; Sonn JK
    Curr Pharm Des; 2020; 26(45):5767-5782. PubMed ID: 32988346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Glimpse into Green Chemistry Practices in the Pharmaceutical Industry.
    Sharma S; Das J; Braje WM; Dash AK; Handa S
    ChemSusChem; 2020 Jun; 13(11):2859-2875. PubMed ID: 32212245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acid hydrolysis of cellulose as the entry point into biorefinery schemes.
    Rinaldi R; Schüth F
    ChemSusChem; 2009; 2(12):1096-107. PubMed ID: 19950346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.